论文信息 - Keratinocyte growth inhibition by high-dose epidermal growth factor is mediated by transforming growth factor beta autoinduction: a negative feedback mechanism for keratinocyte growth.

Keratinocyte growth inhibition by high-dose epidermal growth factor is mediated by transforming growth factor beta autoinduction: a negative feedback mechanism for keratinocyte growth.

The epidermal growth factor receptor and its ligands initiate a major signaling pathway that regulates keratinocyte growth in an autocrine manner. It is well known that high doses of epidermal growth factor receptor ligands inhibit keratinocyte growth. Recently, signal transducers and activators of transcription 1-dependent p21Waf1/Cip1 induction were reported to be involved in high-dose epidermal growth factor-dependent cell growth arrest in the A431 squamous cell carcinoma cell line; however, transfection of dominant-negative signal transducers and activators of transcription 1 adenovirus vector did not block epidermal growth factor-induced growth inhibition in normal human keratinocytes. As transforming growth factor beta is a potent inhibitor of keratinocyte proliferation, we hypothesized that transforming growth factor beta contributes to epidermal growth factor-mediated keratinocyte growth inhibition. Epidermal growth factor concentrations of 10 ng per ml enhanced transforming growth factor beta1 mRNA expression from 3 to 6 h poststimulation. Enzyme-linked immunosorbent assay analysis detected 150 pg per ml of transforming growth factor beta1 in the culture medium of keratinocytes incubated with 10 and 100 ng per ml epidermal growth factor, whereas 0.1 and 1.0 ng per ml epidermal growth factor slightly enhance transforming growth factor beta1 production. Epidermal growth factor (100 ng per ml) upregulated luciferase activity of p3TP-lux, which contains three tandem transforming growth factor beta-Smad signaling responsive elements, 6-fold compared with unstimulated cells. The epidermal growth factor-dependent induction of p3TP-lux luciferase activity was disrupted by transfection of the dominant negative form of transforming growth factor beta type I receptor adenovirus vector (AxdnALK5), which suggests that epidermal growth factor-induced transforming growth factor beta acts in an autocrine manner in keratinocytes. Moreover, transfection of AxdnALK5 completely blocked the growth inhibition induced by 100 ng per ml of epidermal growth factor in normal keratinocytes. These data demonstrate that an autocrine transforming growth factor beta1-ALK5 pathway is a negative feedback mechanism for epidermal growth factor-induced normal human keratinocyte growth.

[1] R. Kerbel,et al. Oncogenes as inducers of tumor angiogenesis , 1995, Cancer and Metastasis Reviews.

[2] L. Wakefield,et al. TGF-β signaling: positive and negative effects on tumorigenesis , 2002 .

[3] C. Liebmann,et al. Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. , 2001, Cellular signalling.

[4] R. Beauchamp,et al. Oncogenic Ras Represses Transforming Growth Factor-β/Smad Signaling by Degrading Tumor Suppressor Smad4* , 2001, The Journal of Biological Chemistry.

[5] A. Sorkin. Internalization of the epidermal growth factor receptor: role in signalling. , 2001, Biochemical Society transactions.

[6] W. F. Bodmer,et al. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7] J. Nicolas,et al. Interferon-gamma production in skin during contact hypersensitivity. No contribution from keratinocytes. , 2001, Journal of Investigative Dermatology.

[8] H. Wiley,et al. Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. , 2001, Molecular biology of the cell.

[9] J. Keski‐Oja,et al. Latency, activation, and binding proteins of TGF‐β , 2001, Microscopy research and technique.

[10] Shigeru Chiba,et al. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis , 2001, Oncogene.

[11] J. Jorcano,et al. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development , 2000, Oncogene.

[12] M. Ohtsubo,et al. Interruption of NFκb–stat1 signaling mediates EGF‐induced cell‐cycle arrest , 2000 .

[13] J. Massagué,et al. Transcriptional control by the TGF‐β/Smad signaling system , 2000 .

[14] K. Miyazono. TGF-β signaling by Smad proteins , 2000 .

[15] X. F. Wang,et al. The Smads: transcriptional regulation and mouse models. , 2000, Cytokine & growth factor reviews.

[16] J. Wrana,et al. Smads as transcriptional co-modulators. , 2000, Current opinion in cell biology.

[17] K. Sayama,et al. Epiregulin, a Novel Member of the Epidermal Growth Factor Family, Is an Autocrine Growth Factor in Normal Human Keratinocytes* , 2000, The Journal of Biological Chemistry.

[18] H. Modjtahedi,et al. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. , 2000, Cancer research.

[19] S. Markowitz. TGF-beta receptors and DNA repair genes, coupled targets in a pathway of human colon carcinogenesis. , 2000, Biochimica et biophysica acta.

[20] I. Stamenkovic,et al. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.

[21] M. Taketo,et al. Gastrointestinal tumorigenesis in Smad4 (Dpc4) mutant mice. , 2000, Human cell.

[22] K. Miyazono,et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. , 1999, Molecular biology of the cell.

[23] L. Dubertret,et al. P16 UV mutations in human skin epithelial tumors , 1999, Oncogene.

[24] H. Friess,et al. The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer , 1999, Oncogene.

[25] James Varani,et al. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor‐stimulated human epidermal keratinocytes , 1999, Journal of cellular physiology.

[26] A. Paterson,et al. Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFα expression in transgenic mice , 1999, Oncogene.

[27] S. Schultz-Cherry,et al. The Activation Sequence of Thrombospondin-1 Interacts with the Latency-associated Peptide to Regulate Activation of Latent Transforming Growth Factor-β* , 1999, The Journal of Biological Chemistry.

[28] A. Ullrich,et al. Epidermal growth factor receptors: critical mediators of multiple receptor pathways. , 1999, Current opinion in cell biology.

[29] M. Matsumoto,et al. Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma , 1999, British Journal of Cancer.

[30] J. Massagué,et al. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway , 1999, Nature.

[31] N. Kaminski,et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.

[32] K. Kinzler,et al. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. , 1999, Cancer research.

[33] H. Beug,et al. TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis , 1998, Current Biology.

[34] J. Grandis,et al. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro. , 1998, The Journal of clinical investigation.

[35] H. Handa,et al. Involvement of MAP kinase-independent protein kinase C signaling pathway in the EGF-induced p21(WAF1/Cip1) expression and growth inhibition of A431 cells. , 1998, Biochemical and biophysical research communications.

[36] D. Rifkin,et al. Interactions between Growth Factors and Integrins: Latent Forms of Transforming Growth Factor-β Are Ligands for the Integrin αvβ1 , 1998 .

[37] B. Lindeman,et al. Endocytosed epidermal growth factor (EGF) receptors contribute to the EGF-mediated growth arrest in A431 cells by inducing a sustained increase in p21/CIP1. , 1998, Experimental cell research.

[38] C. Heldin,et al. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. , 1998, Biochemical and biophysical research communications.

[39] J E Darnell,et al. Epidermal growth factor-induced growth inhibition requires Stat1 activation. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[40] R. Hynes,et al. Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo , 1998, Cell.

[41] M. Emi,et al. A novel missense mutation and frameshift mutations in the type II receptor of transforming growth factor-beta gene in sporadic colon cancer with microsatellite instability. , 1998, Mutation research.

[42] M. Ohtsubo,et al. Antisense oligonucleotide of WAF1 gene prevents EGF-induced cell-cycle arrest in A431 cells , 1998, Oncogene.

[43] Y. Aragane,et al. Down-regulation of interferon γ-activated STAT1 by UV light , 1997 .

[44] M. Kretzschmar,et al. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1 , 1997, Nature.

[45] K. M. Mulder,et al. Transforming growth factor-beta signaling in epithelial cells. , 1997, Pharmacology & therapeutics.

[46] J. Wrana,et al. The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling , 1997, Cell.

[47] D. Rifkin,et al. TGF‐β Latency: Biological Significance and Mechanisms of Activation , 1997 .

[48] J. DiGiovanni,et al. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion , 1997, Oncogene.

[49] N. Shibagaki,et al. Interferon γ-dependent Induction of Human Intercellular Adhesion Molecule-1 Gene Expression Involves Activation of a Distinct STAT Protein Complex* , 1997, The Journal of Biological Chemistry.

[50] M. Ewen. p53-dependent repression of cdk4 synthesis in transforming growth factor-beta-induced G1 cell cycle arrest. , 1996, The Journal of laboratory and clinical medicine.

[51] N. Miyasaka,et al. An Epidermal Growth Factor Receptor/Jak2 Tyrosine Kinase Domain Chimera Induces Tyrosine Phosphorylation of Stat5 and Transduces a Growth Signal in Hematopoietic Cells* , 1996, The Journal of Biological Chemistry.